Light-Activated Targeted Therapy Offers Potential Path to Eradicate Dormant Metastatic Cancer Cells

Summary

Researchers have developed a novel light therapy designed to bypass chemoresistance by targeting cancer cells in their dormant, hibernating state. This breakthrough could significantly improve outcomes for patients dealing with recurrent metastatic disease where standard systemic treatments often fail.

The finding updates the evidence base in the women's health category and is worth reading against prior studies on the same endpoint. Clinical-stage and evidence-dependent operators in the lane feel these prints first.

Sources

• OVUM Primary source